News for hackers. Stuff that matters.
Re:Meta is axing 600 roles across its AI division by janalsncm on Thursday October 23, 2025 @01:51AM (#45678575)
I take your broader point but personally I feel like it’s ok if the FDA is cautious. The incentives that bias towards rejection may be “not killing people”.
Re:Meta is axing 600 roles across its AI division by DebtDeflation on Thursday October 23, 2025 @06:14AM (#45680226)
What about the people who die because a safe and effective drug that could have saved their life got rejected? The problem is that there's a fundamental asymmetry here - those deaths are invisible but deaths from a bad drug that got approved are very visible.
Re:Meta is axing 600 roles across its AI division by mips_avatar on Thursday October 23, 2025 @10:01AM (#45681921)
I mean drugs are different than consumer technology. Instagram isn’t great but it doesn’t cause birth defects. Also things like the compassionate release of hiv drugs in study show the govt can see the nuance here with enough pressure.
Re:Meta is axing 600 roles across its AI division by noosphr on Thursday October 23, 2025 @03:34PM (#45685948)
Yes, but it also doesn't save babies that die from currently incurable diseases.

Always saying no to new tech is "safe" , but it also keeps you in the stone age.

Re:Meta is axing 600 roles across its AI division by dredmorbius on Thursday October 23, 2025 @09:28PM (#45689704)
Or, to cite a more recent example, fast-tracking COVID-19 vaccine approval.
Re:Meta is axing 600 roles across its AI division by esyir on Wednesday October 29, 2025 @10:30AM (#45747328)
I deliberately chose the FDA here specifically because of this. The problem here is that on a societal level, we have to be willing to tolerate some risk. If a drug could have saved many, but is rejected because of occasional complications, that sounds like a poor cost benefit analysis.